Acta Scientific Otolaryngology (ASOL) (ISSN: 2582-5550)

Research Protocol Volume 2 Issue 12

Novel Covid 19 - Associated Otological Symptoms and Role of PRP

BPS Tyagi1,2* and Mamatarani Rout3

1Professor, Head of Department of ENT, Colombia Asia Hospital, Ghaziabad, India
2Head of Department of ENT and CEO, Harsh ENT Hospital, Ghaziabad, India
3Consultant, Department of ENT, Harsh ENT Hospital, Ghaziabad, India

*Corresponding Author: BPS Tyagi, Professor, Head of Department of ENT, Colombia Asia Hospital and CEO, Harsh ENT Hospital, Ghaziabad, India.

Received: November 17, 2020; Published: November 30, 2020

×

Abstract

  A comparative study of effect of Intratympanic Dexamethasone and intratympanic PRP in patients presented to Harsh ENT hospital, Ghaziabad with positive Covid 19, and symptoms like heaviness in ears, vertigo and/or tinnitus, and/or bodyache, and/or hearing loss. There was significant improvement in hearing loss and other otological symptoms in majority of patients with IT PRP compared to IT Dexamethasone.

Keywords: Covid 19; Intratympanic; Dexamethasone; Platelet Rich Plasma

×

Citation

Citation: BPS Tyagi and Mamatarani Rout. “Novel Covid 19 - Associated Otological Symptoms and Role of PRP". Acta Scientific Otolaryngology 2.12 (2020): 63-67.




Metrics

Acceptance rate34%
Acceptance to publication20-30 days
Impact Factor0.871

Indexed In







News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"

Contact US